DRUGS/HHS/PHARMA/TRUMP AS PRESIDENT: “The Trump administration will require drug companies to post their list prices in consumer ads under a proposal to be announced next week — a prominent part of its drug price agenda, according to four individuals with knowledge of the plan. The move — which follows months of battles between the administration, congressional leaders and the pharmaceutical industry — is one of many proposals in President Donald Trump’s blueprint to lower drug prices. But experts caution that the impact may be relatively insignificant and it could even confuse patients, considering the complexities of drug pricing…The administration reiterated its commitment to lowering drug prices, in response to POLITICO’s initial report of the looming proposal…HHS Secretary Alex Azar is scheduled to give a speech Monday afternoon that will address the administration’s drug pricing reforms. The agency’s proposal has been under review by the White House since August and is expected to be published in the Federal Register as soon as Monday [10-12-18]. The rule would be issued through CMS and the agency’s regulatory authority under the Social Security Act.”

Dan Diamond and Sarah Karlin-Smith, “Trump set to force drugmakers to post prices in ads,” Politico, October 12, 2018 3:27 pm